Page 26 - Coronary hemodynamics in acute myocardial infarction - Matthijs Bax

Chapter 1
39. Tarantini G, Ramondo A, Corbetti F, Perazzolo Marra M, Cacciavillani L, Napodano M, Bilato C, Razzolini R and Iliceto S. Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty. Cardiology. 2008;110:129-34.
40. Hollander MR, de Waard GA, Konijnenberg LS, Meijer-van Putten RM, van den Brom CE, Paauw N, de Vries HE, van de Ven PM, Aman J, Van Nieuw-Amerongen GP, Hordijk PL, Niessen HW, Horrevoets AJ and Van Royen N. Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction. PLoS One. 2016;11:e0157233.
41. Mamas MA, Neyses L and Fath-Ordoubadi F. A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Exp Clin Cardiol. 2010;15:e20-4.
42. Allencherril J, Jneid H, Atar D, Alam M, Levine G, Kloner RA and Birnbaum Y. Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon. Cardiovascular Drugs and Therapy. 2019;33:589-597.
43. Shi L, Chen L, Qi G, Tian W and Zhao S. Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta- Analysis of Randomized Controlled Trials. Am J Cardiovasc Drugs. 2020;20:191-198.
44. Gao Q, Yang B, Guo Y and Zheng F. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta- Analysis. Medicine (Baltimore). 2015;94:e1279.
45. Niu X, Zhang J, Bai M, Peng Y, Sun S and Zhang Z. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. BMC Cardiovasc Disord. 2018;18:3.
46. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674-99.
47. Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM and Garcia-Dorado D. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol. 2016;111:70.
48. Hausenloy DJ and Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. The Journal of Clinical Investigation. 2013;123:92-100.
49. Hausenloy DJ, Kharbanda RK, Moller UK, Ramlall M, Aaroe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, Engstrom T, Evans R, Lassen JF, Christensen EF, Garcia-Ruiz JM, Gorog DA, Hjort J, Houghton RF, Ibanez B, Knight R, Lippert FK, Lonborg JT, Maeng M, Milasinovic D, More R, Nicholas JM, Jensen LO, Perkins A, Radovanovic N, Rakhit RD, Ravkilde J, Ryding AD, Schmidt MR, Riddervold IS, Sorensen HT, Stankovic G, Varma M, Webb I, Terkelsen CJ, Greenwood JP, Yellon DM, Botker HE and Investigators C-E-P. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet. 2019;394:1415-1424.
50. Johnson PC. Review of Previous Studies and Current Theories of Autoregulation. Circ Res. 1964;15:SUPPL:2-9.
51. Cornelissen AJ, Dankelman J, VanBavel E and Spaan JA. Balance between myogenic, flow- dependent, and metabolic flow control in coronary arterial tree: a model study. Am J Physiol Heart Circ Physiol. 2002;282:H2224-37.
52. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28:220-31.
53. Goodwill AG, Dick GM, Kiel AM and Tune JD. Regulation of Coronary Blood Flow. Compr Physiol. 2017;7:321-382.
54. Deussen A, Ohanyan V, Jannasch A, Yin L and Chilian W. Mechanisms of metabolic coronary flow regulation. J Mol Cell Cardiol. 2012;52:794-801.
55. Schindler TH, Nitzsche EU, Olschewski M, Brink I, Mix M, Prior J, Facta A, Inubushi M, Just H and Schelbert HR. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med. 2004;45:419-28.
24